| Type | Description |
|---|---|
| Definition | microRNA 103-2 |
| Date | Results | Publications |
|---|---|---|
| 2020-10-24 14:04:00 | MicroRNA-103 represses hepatic de novo lipogenesis and alleviates NAFLD via targeting FASN and SCD1. | 32035613 |
| 2019-06-15 12:28:00 | Study in hypertensive nephropathy patients and angiotensin II (AngII)-infused mice revealed that AngII increases circulating miR-103a-3p levels, which reduces SNRK levels in glomerular endothelial cells, resulting in the over-activation of NF-kappaB/p65 and, consequently, renal inflammation and fibrosis. | 31086184 |
| 2015-11-21 10:56:00 | miR-103 worked through activating AKT/mTOR signal pathway and impairing target gene MEF2D. | 25400071 |
| 2011-02-26 10:58:00 | MiR-103 is involved in IGF-1 stimulated mouse intestinal cell proliferation. | 20886090 |
| Type | IDs |
|---|---|
| Synonymous | Mirn103-2, mir-103-2 |